Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • For authors
    • Instructions for authors
    • Submit a manuscript
    • Author FAQs
    • Open access
    • COVID-19 submission information
  • Alerts
  • Podcasts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • For authors
    • Instructions for authors
    • Submit a manuscript
    • Author FAQs
    • Open access
    • COVID-19 submission information
  • Alerts
  • Podcasts
  • Subscriptions

Bosentan added to sildenafil therapy in patients with pulmonary arterial hypertension

Vallerie McLaughlin, Richard N. Channick, Hossein-Ardeschir Ghofrani, Jean-Christophe Lemarié, Robert Naeije, Milton Packer, Rogério Souza, Victor F. Tapson, Jonathan Tolson, Hikmet Al Hiti, Gisela Meyer, Marius M. Hoeper
European Respiratory Journal 2015 46: 405-413; DOI: 10.1183/13993003.02044-2014
Vallerie McLaughlin
1Department of Internal Medicine, Division of Cardiovascular Medicine, University of Michigan, Ann Arbor, MI, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: vmclaugh@umich.edu
Richard N. Channick
2Pulmonary and Critical Care, Massachusetts General Hospital, Boston, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hossein-Ardeschir Ghofrani
3University of Giessen and Marburg Lung Center, Giessen, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jean-Christophe Lemarié
4Department of Statistics, Effi-Stat, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robert Naeije
5Department of Cardiology, Erasme University Hospital, Brussels, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Milton Packer
6Department of Clinical Sciences, University of Texas Southwestern Medical Center, Dallas, TX, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rogério Souza
7Pulmonary Department, Heart Institute, University of São Paulo Medical School, São Paulo, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Victor F. Tapson
8Division of Pulmonary and Critical Care Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jonathan Tolson
9Global Medical Affairs, Actelion Pharmaceuticals Ltd, Allschwil, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hikmet Al Hiti
10Department of Cardiology, IKEM, Prague, Czech Republic
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gisela Meyer
11Complexo Hospitalar Santa Casa De Porto Alegre, Pulmonary Vascular Research Institute, Porto Alegre, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marius M. Hoeper
12Department of Respiratory Medicine, Hannover Medical School and German Center of Lung Research (DZL), Hannover, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 46 no. 2 405-413
DOI 
https://doi.org/10.1183/13993003.02044-2014
PubMed 
26113687

Published By 
European Respiratory Society
Print ISSN 
0903-1936
Online ISSN 
1399-3003
History 
  • Received November 4, 2014
  • Accepted April 30, 2015
  • Published online July 31, 2015.

Article Versions

  • previous version (June 25, 2015 - 02:09).
  • You are viewing the most recent version of this article.
Copyright & Usage 
Copyright ©ERS 2015

Author Information

  1. Vallerie McLaughlin1⇑,
  2. Richard N. Channick2,
  3. Hossein-Ardeschir Ghofrani3,
  4. Jean-Christophe Lemarié4,
  5. Robert Naeije5,
  6. Milton Packer6,
  7. Rogério Souza7,
  8. Victor F. Tapson8,
  9. Jonathan Tolson9,
  10. Hikmet Al Hiti10,
  11. Gisela Meyer11 and
  12. Marius M. Hoeper12
  1. 1Department of Internal Medicine, Division of Cardiovascular Medicine, University of Michigan, Ann Arbor, MI, USA
  2. 2Pulmonary and Critical Care, Massachusetts General Hospital, Boston, MA, USA
  3. 3University of Giessen and Marburg Lung Center, Giessen, Germany
  4. 4Department of Statistics, Effi-Stat, Paris, France
  5. 5Department of Cardiology, Erasme University Hospital, Brussels, Belgium
  6. 6Department of Clinical Sciences, University of Texas Southwestern Medical Center, Dallas, TX, USA
  7. 7Pulmonary Department, Heart Institute, University of São Paulo Medical School, São Paulo, Brazil
  8. 8Division of Pulmonary and Critical Care Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA
  9. 9Global Medical Affairs, Actelion Pharmaceuticals Ltd, Allschwil, Switzerland
  10. 10Department of Cardiology, IKEM, Prague, Czech Republic
  11. 11Complexo Hospitalar Santa Casa De Porto Alegre, Pulmonary Vascular Research Institute, Porto Alegre, Brazil
  12. 12Department of Respiratory Medicine, Hannover Medical School and German Center of Lung Research (DZL), Hannover, Germany
  1. Vallerie McLaughlin, Department of Internal Medicine, Division of Cardiovascular Medicine, University of Michigan Health System, Ann Arbor, MI 48109-5853, USA. E-mail: vmclaugh{at}umich.edu
View Full Text

Funding

  • Actelion Pharmaceuticals

Article usage

Article usage: June 2015 to December 2020

AbstractFullPdf
Jun 201534642106
Jul 2015827189198
Aug 20152058188300
Sep 20153597594
Oct 2015498159115
Nov 20152768463
Dec 20152467758
Jan 20162015941
Feb 20162515691
Mar 201627647130
Apr 20162024495
May 20162294461
Jun 20161685026
Jul 20161163223
Aug 20162045241
Sep 20162133523
Oct 20161853323
Nov 20162074123
Dec 20161814221
Jan 20171926128
Feb 2017617279
Mar 20171916667
Apr 20171411148
May 2017612358
Jun 201788343
Jul 20171711055
Aug 20171110347
Sep 2017914560
Oct 20171313071
Nov 20171712357
Dec 2017710446
Jan 2018611150
Feb 201859858
Mar 2018011247
Apr 2018111450
May 2018015768
Jun 2018211727
Jul 2018616759
Aug 2018518453
Sep 2018513451
Oct 20181227868
Nov 20181116852
Dec 2018740281
Jan 20191421854
Feb 2019721248
Mar 20191017669
Apr 2019825363
May 20191128164
Jun 20191224751
Jul 20191125146
Aug 2019911244
Sep 2019619688
Oct 2019916876
Nov 201988974
Dec 2019910758
Jan 2020611242
Feb 2020814260
Mar 2020412360
Apr 20201110853
May 2020713469
Jun 2020711852
Jul 2020713450
Aug 2020511146
Sep 202059063
Oct 20201112269
Nov 20201010357
Dec 20202111063

Altmetrics

PreviousNext
Back to top
View this article with LENS
Vol 46 Issue 2 Table of Contents
European Respiratory Journal: 46 (2)
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Bosentan added to sildenafil therapy in patients with pulmonary arterial hypertension
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Alerts
Sign In to Email Alerts with your Email Address
Citation Tools
Bosentan added to sildenafil therapy in patients with pulmonary arterial hypertension
Vallerie McLaughlin, Richard N. Channick, Hossein-Ardeschir Ghofrani, Jean-Christophe Lemarié, Robert Naeije, Milton Packer, Rogério Souza, Victor F. Tapson, Jonathan Tolson, Hikmet Al Hiti, Gisela Meyer, Marius M. Hoeper
European Respiratory Journal Aug 2015, 46 (2) 405-413; DOI: 10.1183/13993003.02044-2014

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Bosentan added to sildenafil therapy in patients with pulmonary arterial hypertension
Vallerie McLaughlin, Richard N. Channick, Hossein-Ardeschir Ghofrani, Jean-Christophe Lemarié, Robert Naeije, Milton Packer, Rogério Souza, Victor F. Tapson, Jonathan Tolson, Hikmet Al Hiti, Gisela Meyer, Marius M. Hoeper
European Respiratory Journal Aug 2015, 46 (2) 405-413; DOI: 10.1183/13993003.02044-2014
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Abstract
    • Abstract
    • Introduction
    • Methods
    • Results
    • Discussion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Subjects

  • Pulmonary vascular disease
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

Original Articles

  • Maternal antibiotic use during pregnancy and asthma in children
  • Hyperglycaemia in cystic fibrosis adversely affects BK channel function
  • Validation of Lung EpiCheck for the detection of lung cancer
Show more Original Articles

Pulmonary vascular diseases

  • Fibrinogen and residual obstruction after pulmonary embolism treatment
  • Risk assessment in medically treated CTEPH patients
  • Exercise RHC, pulmonary endarterectomy in chronic thromboembolic disease
Show more Pulmonary vascular diseases

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Reviewers
  • CME
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Submit a manuscript
  • ERS author centre

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2021 by the European Respiratory Society